The Gross Margin of Sigyn Therapeutics Inc (SIGY) is 75.16%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 75.16% |
| 2022-12-31 | 75.16% |
| 2021-12-31 | 65.49% |
| 2020-12-31 | 44.27% |
| 2019-12-31 | 47.51% |
| 2018-12-31 | 56.12% |
| 2017-12-31 | 41.44% |